Marketscreener, stock market website
60fd35d63471638d18e3bd0dcd.eXvM6dEJkIRxUXwMYiV89kJnHUELj0JXE8UkomDNO3c.SySgvrNh5dVAHjh4L1NJhjsMf3VSwSAFQrF-zTa7eTxJCI-xtDvJvAI0OQ
Logo MarketScreener
Back
Logo MarketScreener

Enter your password

Forgot your password ?
Subscribe
  • Markets
    Stocks
    Top Capitalization
    Australia
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company Calendar
    Equity Analysis
    Most popular
    AIR FRANCE-KLM
    FLUTTER ENTERTAINMENT PLC
    FERRARI N.V.
    BMW AG
    HONEYWELL INTERNATIONAL INC.
    GIFTEE GROUP, INC.
    ABAXX TECHNOLOGIES INC.
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indices News
    SYDNEY ASX
    S&P 500
    NASDAQ 100
    DOW JONES
    FTSE 100
    EURO STOXX 50
    TSX COMP
    HANG SENG
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    AUD / USD
    AUD/CNY
    AUD/JPY
    AUD/EUR
    AUD/SGD
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Markets
    Emerging Markets
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Funds
    Economy
    Sectors
    All our articles
    Most Read News
    Key News
    Business Insiders
  • Analysis
    All Articles
    Must Read
    Interviews
    Stocks
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Interest Rates
  • Calendar
    Economic Calendar
    Company Calendar
    Dividend calendar
  • Stock Picks
    All our investments
    Europe
    United States
    Asia, Pacific
  • Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Quality stocks at a reasonable price
    Dividend Kings
    Undervalued stocks
    Multibaggers
    Dividend Aristocrats
    Trend-Following Stocks
    Investment Themes
    Homepage
    Education
    The food of tomorrow
    Defense
    The Golden Age of Video Games
    E-Commerce & Logistics
    Luxury
  • Trading
    Market Timing
    Key News
    Pre/Post-Market Movers
    Technical Alerts
  • Screeners
    Stocks
    ETF
    Insider Transactions
  • Tools
    Advanced Chart
    Currency Converter
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual Volumes
    New Historical Highs
    New Historical Lows
    Pre/Post-Market Movers
    Top Fundamentals
    Fundamental Composite
    Sales Growth
    Earnings Growth
    Profitability
    Finances
    Visibility Rankings
    Rankings Valuation
    Valuation Composite
    Market Cap
    P/E
    Enterprise Value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus Composite
    Analyst Opinion
    Target Price
    Opinion Divergences
    Estimates Revisions
    Analyst Coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
Australian Edition
Subscribe
  • Homepage
  • Markets
    • Stocks
      • Top Capitalization
      • Australia
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company Calendar
      • Equity Analysis
      • Most popular
      • AIR FRANCE-KLM
      • FLUTTER ENTERTAINMENT PLC
      • FERRARI N.V.
      • BMW AG
      • HONEYWELL INTERNATIONAL INC.
      • GIFTEE GROUP, INC.
      • ABAXX TECHNOLOGIES INC.
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indices News
      • SYDNEY ASX
      • S&P 500
      • NASDAQ 100
      • DOW JONES
      • FTSE 100
      • EURO STOXX 50
      • TSX COMP
      • HANG SENG
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • AUD / USD
      • AUD/CNY
      • AUD/JPY
      • AUD/EUR
      • AUD/SGD
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Markets
      • Emerging Markets
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Funds
    • Economy
    • Sectors
    • All our articles
    • Most Read News
    • Key News
    • Business Insiders
  • Analysis
    • All Articles
    • Must Read
    • Interviews
    • Stocks
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Interest Rates
  • Calendar
    • Economic Calendar
    • Company Calendar
    • Dividend calendar
  • Stock Picks
    • All our investments
    • Europe
    • United States
    • Asia, Pacific
  • Portfolios
    • European Portfolio
    • USA Portfolio
    • Asian Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Quality stocks at a reasonable price
      • Dividend Kings
      • Undervalued stocks
      • Multibaggers
      • Dividend Aristocrats
      • Trend-Following Stocks
    • Investment Themes
      • Homepage
      • Education
      • The food of tomorrow
      • Defense
      • The Golden Age of Video Games
      • E-Commerce & Logistics
      • Luxury
  • Trading
    • Market Timing
    • Key News
    • Pre/Post-Market Movers
    • Technical Alerts
  • Screeners
    • Stocks
    • ETF
    • Insider Transactions
  • Tools
    • Advanced Chart
    • Currency Converter
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual Volumes
      • New Historical Highs
      • New Historical Lows
    • Pre/Post-Market Movers
    • Top Fundamentals
      • Fundamental Composite
      • Sales Growth
      • Earnings Growth
      • Profitability
      • Finances
      • Visibility Rankings
    • Rankings Valuation
      • Valuation Composite
      • Market Cap
      • P/E
      • Enterprise Value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus Composite
      • Analyst Opinion
      • Target Price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst Coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
Switch edition
Stock APVO APTEVO THERAPEUTICS INC.
Add to a list

Aptevo Therapeutics Inc. Nasdaq

Stocks

APVO

US03835L5049

Biotechnology & Medical Research

Delayed
Nasdaq
04:04:23 12/09/26 am AEST
5-day change 1st Jan Change
1.850 USD +1.09% Intraday chart for Aptevo Therapeutics Inc. +6.32% -80.38%
14/08 Aptevo Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
28/07 Aptevo Therapeutics Inc. Announces New Solid Tumor Strategy and Filing of Patent Application Covering Proprietary Nectin-4 X PD-L1 Dual-Targeting Backbone CI
Summary
Quotes
Charts
Technical Analysis Static Chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Insider Transactions Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Top Midday Decliners

Published on 12/27/2025 at 06:32 am AEDT

MT Newswires
This article is reserved for our members.
Log in to continue
Continue with Google Continue with Apple Continue with LinkedIn
or by email
Continue with an email.
Create an account with Google Create an account with Apple Create an account with LinkedIn
or by email
Create an account
For unlimited access, Check out our subscriptions.

Latest news about Aptevo Therapeutics Inc.

14/08 Aptevo Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
28/07 Aptevo Therapeutics Inc. Announces New Solid Tumor Strategy and Filing of Patent Application Covering Proprietary Nectin-4 X PD-L1 Dual-Targeting Backbone CI
10/06 Aptevo Therapeutics Inc. And Niowave Inc. Join Forces To Advance Novel Targeted Cancer Therapeutics In The USD 17,000 million Oncology Category CI
29/05 Aptevo Therapeutics Inc. Appoints Mary J. Janatpour as Senior Vice President & Chief Scientific Officer CI
28/05 Aptevo Therapeutics Inc. And Niowave Inc. Launch Strategic Collaboration For Radiopharmaceutical Therapeutic Development CI
14/05 Aptevo Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
07/05 Aptevo Therapeutics Inc Reports Clinical Results and Provides Update on Rainier Frontline Acute Myeloid Leukemia Trial CI
28/03 Aptevo Therapeutics Inc. Shows 86% Clinical Benefit Rate For Mipletamig In Frontline AML CI
27/03 Aptevo Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
26/03 Aptevo Therapeutics Inc. Auditor Raises 'Going Concern' Doubt CI
11/03 Aptevo Therapeutics Inc Announces New Interim Data For Mipletamig In Combination With Venetoclax And Azacitidine CI
04/02 Aptevo Announces CEO Changes CI
04/02 Aptevo Therapeutics Inc. Announces Board and Executive Changes CI
04/02 Aptevo Therapeutics Inc - Marvin White to retire as Aptevo CEO effective April 1, 2026 - SEC filing RE
29/01 Aptevo Therapeutics prospectus relates to offer and sale of up to 7,075,471 shares of our common stock by selling stockholder RE

Chart Aptevo Therapeutics Inc.

Chart Aptevo Therapeutics Inc.
APVO: Dynamic Chart

Company Profile

Logo Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer. The Company has two clinical candidates: Mipletamig and ALG.APV-527. Mipletamig is being evaluated in RAINIER, a two-part Phase 1b/2 trial for the treatment of frontline acute myeloid leukemia in combination with standard-of-care venetoclax + azacitidine. Mipletamig has received orphan drug designation for AML according to the Orphan Drug Act. ALG.APV-527, a bispecific conditional 4-1BB agonist, only active upon simultaneous binding to 4-1BB and 5T4, is being co-developed with Alligator Bioscience and is being evaluated in a Phase 1 clinical trial for the treatment of multiple solid tumor types likely to express 5T4. The Company has three pre-clinical candidates with different mechanisms of action designed to target a range of solid tumors. All pipeline candidates are created from two proprietary platforms, ADAPTIR and ADAPTIR-FLEX.
Employees
-
Sector
Biotechnology & Medical Research
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

-
Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.

-
Quality

Quality

This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.

-
ESG MSCI

ESG MSCI

The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.830USD
Average target price
25.50USD
Spread / Average Target
+1,293.44%
Consensus
EPS Estimates
Revisions to estimates
Indices Europe America Asia

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

  1. Stock Market
  2. Stock Market News
  3. Top Midday Decliners
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
1,300,000 +members

1,300,000 +
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-6pm CET

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!
DAILY FREE LIMIT REACHED
To continue browsing,
Sign up!
Extended daily access
Personal watchlists and screeners
Real-time market news
Access the "Discovery" Stock Screener (covering 30,000 companies)
Create your free account
Become a member and join over 1 million active investors
or
Already have an account? Log in

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong